Comprehensive genomic, immunological and clinical analysis of COVID-19 vaccine breakthrough infections: a prospective, comparative cohort study
Di Tian(Capital Medical University), Wenbo Xu(Shenyang Institute of Automation), Jing Wen(East China Normal University), Yang Song(National Institute for Viral Disease Control and Prevention), Zhihai Chen(Capital Medical University), Ziruo Ge(Capital Medical University), Man Zhang(Guiyang Medical University), Yao Zhang(Fudan University), Peng Yang(Rutgers, The State University of New Jersey), Hongxia Guo(National Institute for Viral Disease Control and Prevention), Xingxiang Ren(Capital Medical University), Yanli Xu(Capital Medical University), Yang Pan(Beijing Center for Disease Prevention and Control)
Cited by 0
Related Papers
A Novel Coronavirus from Patients with Pneumonia in China, 2019
|New England Journal of Medicine|2020|30.5k
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
|The Lancet|2020|12.6k
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
|Nature|2020|1.2k